Complementary therapy use and quality of life in persons with high-grade gliomas.
Studies have indicated that 30%-80% of cancer patients use complementary and alternative practices and products (CAPPs), but little is known about CAPPs use by persons with brain tumors. This secondary analysis of Glioma Outcomes Project data compared CAPPs users with nonusers, compared those who stopped using CAPPs with those who continued use, described frequency and patterns of CAPPs use, and compared the relationship of CAPPs use to self-reported quality of life (QOL) over time, in 186 persons with high-grade gliomas. CAPPs users at all three measurement points rated QOL higher, although not significantly higher, than nonusers. Study findings support further exploration of CAPPs use and its effects on key outcomes in persons with high-grade gliomas.
Fox
Sherry
S
University of Virginia School of Nursing, Charlottesville, USA. foxsherry@aol.com
Laws
Edward R
ER
Anderson
Frederick
F
Farace
Elana
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000401:mortality / Q000523:psychology* / Q000628:therapy; D002170:Canada / Q000453:epidemiology; D016009:Chi-Square Distribution; D000529:Complementary Therapies / Q000523:psychology / Q000706:statistics & numerical data; D005260:Female; D005910:Glioma / Q000401:mortality / Q000523:psychology* / Q000628:therapy; D019538:Health Care Surveys; D006304:Health Status; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D015404:Nursing Methodology Research; D010342:Patient Acceptance of Health Care / Q000523:psychology* / Q000706:statistics & numerical data; D011788:Quality of Life / Q000523:psychology*; D011795:Surveys and Questionnaires; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology